調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別

◆タイトル：Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022
◆商品コード：MAM-MD-6041
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年2月27日
◆ページ数：138
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、ペン型注射器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ペン型注射器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・ペン型注射器市場：タイプ別
・ペン型注射器市場：治療方法別
・ペン型注射器市場：エンドユーザー別
・ペン型注射器市場：地域別
・競争状況
・企業プロファイル
・付録

“The injection pen market is projected to grow at a CAGR of 6.0% during the forecast period”
The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.

“By type, the disposable injection pens segment is expected to grow at the highest rate during the forecast period (2017–2022).”
Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.

“By therapy, the diabetes segment is expected to grow at the highest CAGR during the study period.”
Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.

“The North American injection pen market is expected to grow at the highest CAGR during the forecast period”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
Research Coverage:
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the injection pen market. The report analyzes the market based on type, therapy, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the injection pen market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various injection pens across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the injection pen market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DESIGN 18
2.2 RESEARCH APPROACH 19
2.2.1 SECONDARY RESEARCH 20
2.2.2 PRIMARY RESEARCH 21
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 26
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
4.1 GLOBAL INJECTION PEN MARKET OVERVIEW 33
4.2 GLOBAL INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022 34
4.3 GEOGRAPHIC ANALYSIS: GLOBAL INJECTION PEN MARKET, BY THERAPY 35
4.4 GLOBAL INJECTION PEN MARKET, BY END USER, 2017 VS. 2022 36
4.5 GEOGRAPHIC SNAPSHOT: GLOBAL INJECTION PEN MARKET 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Growing Prevalence of Chronic Diseases 38
5.2.1.2 Increasing number of regulatory approvals 38
5.2.1.3 Favorable reimbursement and government support 39
5.2.2 RESTRAINTS 39
5.2.2.1 Preference for alternative drug delivery modes 39
5.2.2.2 Poor reimbursement scenario in developing countries 40
 
5.2.3 OPPORTUNITIES 40
5.2.3.1 Patent expiry of biologics to drive the demand for biosimilars 40
5.2.4 CHALLENGES 40
5.2.4.1 Needle-stick injuries & misuse of injection pen 40
6 INJECTION PEN MARKET, BY TYPE 42
6.1 INTRODUCTION 43
6.1.1 DISPOSABLE INJECTION PEN 44
6.1.2 REUSABLE INJECTION PEN 44
7 INJECTION PEN MARKET, BY THERAPY 46
7.1 INTRODUCTION 47
7.2 DIABETES 48
7.2.1 INSULIN 49
7.2.2 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) 50
7.3 GROWTH HORMONE THERAPY 51
7.4 OSTEOPOROSIS 52
7.5 FERTILITY 53
7.6 OTHER THERAPIES 54
8 INJECTION PEN MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOME CARE 57
8.3 HOSPITALS & CLINICS 58
9 INJECTION PEN MARKET, BY REGION 59
9.1 INTRODUCTION 60
9.2 NORTH AMERICA 61
9.2.1 US 63
9.2.2 CANADA 67
9.3 EUROPE 69
9.3.1 UK 72
9.3.2 GERMANY 74
9.3.3 FRANCE 76
9.3.4 REST OF EUROPE 78
9.4 ASIA PACIFIC 81
9.4.1 CHINA 84
9.4.2 JAPAN 85
9.4.3 INDIA 87
9.4.4 ROAPAC 89
9.5 ROW 91
 
10 COMPETITIVE LANDSCAPE 94
10.1 OVERVIEW 94
10.2 MARKET RANKING OF OEM COMPANIES 94
10.3 MARKET SHARE ANALYSIS 95
10.4 COMPETITIVE SCENARIO 97
10.4.1 PRODUCT LAUNCHES 98
10.4.2 REGULATORY APPROVALS 98
10.4.3 EXPANSIONS 99
10.4.4 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 99
10.4.5 ACQUISITIONS 100
11 COMPANY PROFILES 101
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 NOVO NORDISK 101
11.2 SANOFI 105
11.3 ELI LILLY AND COMPANY 108
11.4 MERCK 111
11.5 YPSOMED 113
11.6 ASTRAZENECA 116
11.7 F.HOFFMAN-LA ROCHE 118
11.8 BECTON, DICKINSON AND COMPANY (BD) 120
11.9 OWEN MUMFORD 122
11.11 NOVARTIS 123
11.12 PFIZER 125
11.13 HASELMEIER 127
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 129
12.1 DISCUSSION GUIDE 129
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 132
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 134
12.4 AVAILABLE CUSTOMIZATIONS 134
12.5 RELATED REPORTS 135
12.6 AUTHOR DETAILS 136

LIST OF TABLES

TABLE 1 INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 43
TABLE 2 DISPOSABLE INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 3 REUSABLE INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 4 INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 47
TABLE 5 INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 48
TABLE 6 INJECTION PEN MARKET FOR DIABETES THERAPY, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 7 INJECTION PEN MARKET FOR INSULIN THERAPY, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 8 INJECTION PEN MARKET FOR GLP-1 THERAPY, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 9 INJECTION PEN MARKET FOR GROWTH HORMONE THERAPY, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 10 INJECTION PEN MARKET FOR OSTEOPOROSIS THERAPY, BY REGION,
2015–2022 (USD MILLION) 52
TABLE 11 INJECTION PEN MARKET FOR FERTILITY THERAPY, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 12 INJECTION PEN MARKET FOR OTHER THERAPIES, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 13 INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 56
TABLE 14 INJECTION PEN MARKET FOR HOME CARE, BY REGION,
2015–2022 (USD MILLION) 57
TABLE 15 INJECTION PEN MARKET FOR HOSPITALS & CLINICS, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 16 INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 17 NORTH AMERICA: INJECTION PEN MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 18 NORTH AMERICA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 62
TABLE 19 NORTH AMERICA: INJECTION PEN MARKET, BY THERAPY,
2015–2022 (USD MILLION) 62
TABLE 20 NORTH AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015–2022 (USD MILLION) 63
TABLE 21 NORTH AMERICA: INJECTION PEN MARKET, BY END USER,
2015–2022 (USD MILLION) 63
TABLE 22 FDA APPROVALS OF INJECTION PEN (2014–2017) 64
TABLE 23 US: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 66
TABLE 24 US: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 66
TABLE 25 US: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 66
TABLE 26 US: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 67
TABLE 27 CANADA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 67
TABLE 28 CANADA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 68
TABLE 29 CANADA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 68
TABLE 30 CANADA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 68
TABLE 31 APPROVALS OF INJECTION PEN (2014–2017) 70
TABLE 32 EUROPE: INJECTION PEN MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 70
TABLE 33 EUROPE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 34 EUROPE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 71
TABLE 35 EUROPE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 71
TABLE 36 EUROPE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 71
TABLE 37 UK: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 73
TABLE 38 UK: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 73
TABLE 39 UK: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 73
TABLE 40 UK: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 74
TABLE 41 GERMANY: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 75
TABLE 42 GERMANY: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 75
TABLE 43 GERMANY: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 44 GERMANY: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 76
TABLE 45 FRANCE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 76
TABLE 46 FRANCE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 77
TABLE 47 FRANCE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 77
TABLE 48 FRANCE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 77
TABLE 49 ROE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 50 ROE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 79
TABLE 51 ROE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 80
TABLE 52 ROE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 80
TABLE 53 ASIA PACIFIC: INJECTION PEN MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 82
TABLE 54 ASIA PACIFIC: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 82
TABLE 55 ASIA PACIFIC: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 83
TABLE 56 ASIA PACIFIC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 83
TABLE 57 ASIA PACIFIC: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 83
TABLE 58 CHINA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 84
TABLE 59 CHINA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 84
TABLE 60 CHINA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 85
TABLE 61 CHINA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 85
TABLE 62 JAPAN: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 86
TABLE 63 JAPAN: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 86
TABLE 64 JAPAN: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 86
TABLE 65 JAPAN: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 87
TABLE 66 INDIA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 87
TABLE 67 INDIA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 88
TABLE 68 INDIA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 69 INDIA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 88
TABLE 70 ROAPAC: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 89
TABLE 71 ROAPAC: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 90
TABLE 72 ROAPAC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 90
TABLE 73 ROAPAC: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 90
TABLE 74 ROW: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 92
TABLE 75 ROW: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 92
TABLE 76 ROW: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 93
TABLE 77 ROW: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 93
TABLE 78 PRODUCT LAUNCHES (2014-2017) 98
TABLE 79 REGULATORY APPROVALS 98
TABLE 80 EXPANSIONS 99
TABLE 81 AGREEMENTS AND PARTNERSHIPS 99
TABLE 82 ACQUISITIONS 100


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: GLOBAL INJECTION PEN MARKET 18
FIGURE 2 GLOBAL INJECTION PEN MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 3 SAMPLING FRAME: PRIMARY INSIGHTS 22
FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 5 PRIMARY SOURCES 23
FIGURE 6 KEY INDUSTRY INSIGHTS 24
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 25
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 9 DATA TRIANGULATION METHODOLOGY 26
FIGURE 10 DISPOSABLE INJECTION PEN DOMINATED THE MARKET IN 2017 28
FIGURE 11 DIABETES SEGMENT DOMINATED THE INJECTION PEN MARKET,
BY THERAPY (2017) 29
FIGURE 12 INSULIN SEGMENT DOMINATED THE GLOBAL INJECTION PEN MARKET FOR DIABETES, BY TYPE (2017) 30
FIGURE 13 HOME CARE SEGMENT DOMINATED THE INJECTION PEN MARKET,
BY END USER (2017) 31
FIGURE 14 NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD 32
FIGURE 15 GROWING PREVALENCE OF CHRONIC DISEASES, INCREASING NUMBER OF REGULATORY APPROVALS, AND FAVORABLE REIMBURSEMENT AND GOVERNMENT SUPPORT ARE DRIVING MARKET GROWTH 33
FIGURE 16 DISPOSABLE INJECTION PEN SEGMENT DOMINATED THE MARKET IN 2017 34
FIGURE 17 DIABETES THERAPY DOMINATED THE GLOBAL INJECTION PEN MARKET IN 2017 35
FIGURE 18 HOME CARE ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017 36
FIGURE 19 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 36
FIGURE 20 INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION) 43
FIGURE 21 INJECTION PEN MARKET, BY THERAPY, 2017 VS. 2022 (USD MILLION) 47
FIGURE 22 INJECTION PEN MARKET, BY END USER, 2017 VS. 2022 (USD MILLION) 56
FIGURE 23 NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017 60
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 61
FIGURE 25 EUROPE: MARKET SNAPSHOT 69
FIGURE 26 ASIA PACIFIC: MARKET SNAPSHOT 81
FIGURE 27 ROW: MARKET SNAPSHOT 91
FIGURE 28 GLOBAL INJECTION PEN MARKET RANKING BY OEM COMPANIES (AS OF 2016) 94
FIGURE 29 INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2016 95
FIGURE 30 STRATEGIES ADOPTED BY MARKET PLAYERS (2014–2017) 97
FIGURE 31 NOVO NORDISK: COMPANY SNAPSHOT (2016) 101
FIGURE 32 SANOFI: COMPANY SNAPSHOT (2016) 105
FIGURE 33 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2016) 108
FIGURE 34 MERCK: COMPANY SNAPSHOT (2016) 111
FIGURE 35 YPSOMED: COMPANY SNAPSHOT (2016) 113
FIGURE 36 ASTRAZENECA: COMPANY SNAPSHOT (2016) 116
FIGURE 37 F.HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2016) 118
FIGURE 38 BD: COMPANY SNAPSHOT (2016) 120
FIGURE 39 NOVARTIS: COMPANY SNAPSHOT (2016) 123
FIGURE 40 PFIZER: COMPANY SNAPSHOT (2016) 125


★調査レポート[ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別] ( Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022 / MAM-MD-6041) 販売に関する免責事項
[ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別] ( Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022 / MAM-MD-6041) についてEメールでお問い合わせ
◆関連調査資料◆
  • 渦巻きポンプの世界市場予測（～2022年）：タイプ別（片持インペラ、立形、両持）、段数別（一段、多段）、エンドユーザー別（水と排水、化学品、オイルとガス、電力、商業と住宅）、地域別
    MAM-EP-5975 / MarketsandMarkets / 2018年2月8日 / MarketsandMarketsが発行した当調査レポートでは、渦巻きポンプの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、セグメント別分析、地域別分析、渦巻きポンプの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・渦巻きポンプ市場：タイプ別 ・渦巻きポンプ市場：段数別 ・渦巻きポンプ市場：エンドユーザー産業別 ・渦巻きポンプ市場：地域別...“The centrifugal pump market is projected to grow at a CAGR of 3.83%, from 2017 to 2022.” The centrifugal pump market is projected to grow from an estimated USD 30.65 billion in 2017 to USD 36.98 billion by 2022, at a CAGR of 3.83%, from 2017 to 2022. Increasing investments in modernizing water and wastewater infrastructure, infrastructure development, and power generation in emerging economies and the growth of industries such as chemicals and manufacturing is driving the market for centrifugal pumps across the world. “The industrial segment is expected to hold the largest share of the centrifugal pump market, by...
  • 敷地内冷却塔の世界市場予測（～2022年）：タイプ別（湿式、乾式、ハイブリッド）、デザイン別（天然、強制、誘引通風）、エンドユーザー別（発電、石油化学、石油とガス、鉄とスチール、冶金、製紙）、地域別
    MAM-EP-4210 / MarketsandMarkets / 2018年2月14日 / MarketsandMarketsが発行した当調査レポートでは、敷地内冷却塔の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、セグメント別分析、地域別分析、敷地内冷却塔の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・敷地内冷却塔市場：タイプ別 ・敷地内冷却塔市場：デザイン別 ・敷地内冷却塔市場：エンドユーザー別 ・敷地内冷却塔市場：地域別...“The field-erected cooling tower market is projected to grow at a CAGR of 3.78%, from 2017 to 2022.” The field-erected cooling tower market is projected to grow from an estimated USD 1.78 billion in 2017 to USD 2.15 billion by 2022, at a CAGR of 3.78%, from 2017 to 2022. Stringent environmental regulations and growth in industrial activities are driving the demand for the field-erected cooling tower market across the world. The rise in alternative energy programs is a restraint for the field-erected cooling tower market. “The power generation segment is expected to hold the largest share of the field-erected...
  • 長石市場の世界市場予測（～2022年）：タイプ別（斜長石、カリ長石）、エンドユーザー別（ガラス、セラミックス、フィラー）、地域別（ヨーロッパ、北米、南米、太平洋アジア、中東とアフリカ）
    MAM-MM-5967 / MarketsandMarkets / 2018年2月5日 / MarketsandMarketsが発行した当調査レポートでは、長石市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場環境分析、種類別分析、セグメント別分析、地域別分析、長石市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・長石市場：タイプ別 ・長石市場：エンドユーズ別 ・長石市場：地域別 ・企業プロファイル...“Increasing use of feldspar for ceramic manufacturing due to the growing residential and commercial infrastructure is a major driving factor for the feldspar market” The feldspar market is estimated to be USD 547.0 million in 2017 and is projected to reach USD 745.7 million by 2022, at a CAGR of 6.4%, in terms of value, between 2017 and 2022. The market is witnessing high growth because of the increasing use of feldspars in glass, ceramics, and as fillers. Feldspars act as a fluxing agent and are majorly used during the manufacturing of glass and ceramics. They are used to impart...
  • 関節鏡視下手術用器具の世界市場予測（～2022年）：タイプ別(インプラント、関節鏡、可視化システム、手術用シェーバー、高周波(RF)アブレーション、流体管理)、用途別(膝、腰、肩)、エンドユーザー別(病院、外来外科センター・クリニック)
    MAM-MD-6017 / MarketsandMarkets / 2018年2月21日 / MarketsandMarketsが発行した当調査レポートでは、関節鏡視下手術用器具の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、関節鏡視下手術用器具の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・関節鏡視下手術用器具市場：商品別 ・関節鏡視下手術用器具市場：用途別 ・関節鏡視下手術用器具市場：エンドユーザー別 ・関節鏡視下手術用器具市場：地域別...“Arthroscopy instruments market is projected to grow at a CAGR of 6.1%” The global arthroscopy instruments market is projected to reach USD 5.61 billion by 2022 from USD 4.17 billion in 2017, at a CAGR of 6.1%. Factors such as the high incidence of sports and trauma injuries; growing aging population; technological developments; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. However, the unfavorable reimbursement scenarios in most developing countries and budgetary constraint of hospitals to expand their infrastructure are expected to restrain the growth of this market to a...
  • バッテリー監視システムの世界市場予測（～2022年）：構成要素別（ハードウェア、ソフトウェア）、タイプ別（有線、無線）、電池タイプ別（リチウムイオンベース、鉛蓄電池）、エンドユーザー別（電気通信、自動車、エネルギー、産業）、地域別
    MAM-EP-5981 / MarketsandMarkets / 2018年2月9日 / MarketsandMarketsが発行した当調査レポートでは、バッテリー監視システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、セグメント別分析、地域別分析、バッテリー監視システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・バッテリー監視システム市場：構成要素別 ・バッテリー監視システム市場：タイプ別 ・バッテリー監視システム市場：電池タイプ別 ・バッテリー監視システム市場：エンドユーザー別...“The battery monitoring system market is projected to grow at a CAGR of 18.23%, from 2017 to 2022.” The battery monitoring system market is projected to reach USD 5.47 billion by 2022, from an estimated USD 2.37 billion in 2017, at a CAGR of 18.23%, during the forecast period. The need to prevent unplanned outages, increasing demand for electric vehicles, and improved operational efficiency of batteries have boosted the demand for battery monitoring systems. In addition, increasing renewable power generation and the growing use of battery monitoring systems in data center applications would further aid the growth of this market....
  • 甲状腺機能検査の世界市場予測（～2022年）：タイプ別(TSH検査、T4検査、T3検査）、エンドユーザー別(病院、診断ラボ、研究ラボ・機関)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)
    MAM-BT-6032 / MarketsandMarkets / 2018年2月23日 / MarketsandMarketsが発行した当調査レポートでは、甲状腺機能検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、甲状腺機能検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・甲状腺機能検査市場：タイプ別 ・甲状腺機能検査市場：エンドユーザー別 ・甲状腺機能検査市場：地域別 ・競争状況...“The thyroid function tests market is projected to grow at a CAGR of 5.9%.” The global thyroid function tests market is projected to reach USD 1.68 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 5.9% during the forecast period. Growth in the market can primarily be attributed to factors such as increasing incidence of thyroid disorders, increasing awareness about thyroid disorders, increasing prevalence of lifestyle diseases, rising geriatric population, and increasing consumption of alcohol and tobacco. However, unfavorable healthcare reforms in the US are likely to restrain the growth of this market to...
  • 可変速発電機の世界市場予測（～2022年）：タイプ別（永久磁石同期発電機・二重給電誘導発電機・自励誘導発電機・巻線形誘導発電機）、原動機別（風力タービン、ハイドロタービン、蒸気・ガスタービン、内燃機関）、技術別、パワー別、エンドユーザー別、地域別
    MAM-EP-5962 / MarketsandMarkets / 2018年2月5日 / MarketsandMarketsが発行した当調査レポートでは、可変速発電機の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、セグメント別分析、地域別分析、可変速発電機の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・可変速発電機市場：発電機タイプ別 ・可変速発電機市場：技術タイプ別 ・可変速発電機市場：電力定格別 ・可変速発電機市場：原動機別...“The variable speed generator market is projected to grow at a CAGR of 7.63%, from 2017 to 2022.” The global variable speed generator market is estimated at USD 5.79 billion in 2017 and is projected to grow at a CAGR of 7.63% to reach USD 8.36 billion by 2022. This growth is primarily due to the increasing emphasis on alternative energy production, increasing government mandates over energy efficiency, and growing industrialization and urbanization. Although some cost bearing constraints in the installation of variable speed generators are being observed, still emerging economies are expected to create better opportunities for the variable...
  • CROサービスの世界市場予測（～2023年）：タイプ別（創薬研究、ＣＭＣ、前臨床、臨床研究、ラボサービス）、治療領域別（腫瘍、CNS、心臓血管）、エンドユーザー別（医薬品と医療機器）
    MAM-PH-4672 / MarketsandMarkets / 2018年2月2日 / MarketsandMarketsが発行した当調査レポートでは、CROサービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、セグメント別分析、地域別分析、CROサービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・CROサービス市場：タイプ別 ・グローバルCROサービス市場：治療領域別 ・CROサービス市場：エンドユーザー別 ・CROサービス市場：地域別...“The Contract Research Organization (CRO) services market is projected to grow at a CAGR of 7.6% between 2018 and 2023.” The CRO services market is expected to reach USD 56.34 billion by 2023 from USD 39.13 billion in 2018, at a CAGR of 7.6%. Increased outsourcing of R&D activities and increasing number of clinical trials are some of the major factors driving the growth of this market. However, intense competition in the CRO services market is one of the major challenges for the players operating in the CRO services market. “Laboratory services segment to witness the highest growth rate during...
  • 発電機販売の世界市場予測（～2023年）：タイプ別（ディーゼル、ガス）、用途別（予備電源、主電源 & 常時電源、ピークシェービング）、電力定格別（<100 kVA、100?350 kVA、350?1,000 kVA、>1,000 kVA）、エンドユーザー別（住宅、商業、産業）、地域別
    MAM-EP-3131 / MarketsandMarkets / 2018年2月14日 / MarketsandMarketsが発行した当調査レポートでは、発電機販売の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、セグメント別分析、地域別分析、発電機販売の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・発電機販売市場：燃料タイプ別 ・発電機販売市場：電力定格別 ・発電機販売市場：用途別 ・発電機販売市場：エンドユーザー別...“The generator sales market is projected to grow at a CAGR of 5.41%, from 2018 to 2023.” The generator sales market is estimated to reach USD 20.93 billion in 2018 and USD 27.24 billion by 2023, at a CAGR of 5.41%, from 2018 to 2023. Generators can be used in standby, prime, continuous, and peak shaving applications in various end-use sectors such as industrial, commercial, and residential. The main driver for the generator sales market is the growing demand for uninterrupted and reliable power supply as some of the best power grids are also subject to downtime. The growth of...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆